Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 83963 [2020-28380]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 247 / Wednesday, December 23, 2020 / Notices
exposed in the incident. Part III requires
SkyMed to establish and implement,
and thereafter maintain, a
comprehensive information security
program that protects the security,
confidentiality, and integrity of
consumers’ personal information.
Part IV requires SkyMed to obtain
initial and biennial data security
assessments for twenty years. Part V of
the Proposed Order requires SkyMed to
disclose all material facts to the assessor
and prohibits SkyMed from
misrepresenting any fact material to the
assessments required by Part IV.
Part VI requires SkyMed to submit an
annual certification from a senior
corporate manager (or senior officer
responsible for its information security
program) that SkyMed has implemented
the requirements of the Order and is not
aware of any material noncompliance
that has not been corrected or disclosed
to the Commission. Part VII requires
SkyMed to notify the Commission any
time (1) it is required to make a
notification to a federal, state, or local
government that personal information
has been breached or disclosed, or (2)
individually identifiable health
information from or about a consumer
was, or is reasonably believed to have
been, accessed, acquired, or publicly
exposed without authorization.
Parts VIII through XI are reporting and
compliance provisions, which include
recordkeeping requirements and
provisions requiring SkyMed to provide
information or documents necessary for
the Commission to monitor compliance.
Part XII states that the Proposed Order
will remain in effect for twenty years,
with certain exceptions.
The purpose of this analysis is to aid
public comment on the Proposed Order.
It is not intended to constitute an
official interpretation of the complaint
or Proposed Order, or to modify in any
way the Proposed Order’s terms.
By direction of the Commission.
April J. Tabor,
Acting Secretary.
[FR Doc. 2020–28262 Filed 12–22–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jbell on DSKJLSW7X2PROD with NOTICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW)
ACTION:
Notice.
VerDate Sep<11>2014
21:21 Dec 22, 2020
Jkt 253001
SUMMARY: The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ACBCYW. The ACBCYW consists of 15
experts in fields associated with breast
cancer, disease prevention, early
detection, diagnosis, public health,
social marketing, genetic screening and
counseling, treatment, rehabilitation,
palliative care, and survivorship in
young women, or in related disciplines
with a specific focus on young women.
DATES: Nominations for membership on
the ACBCYW must be received no later
than March 12, 2021. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Jeremy McCallister, c/o
ACBCYW Secretariat, Centers for
Disease Control and Prevention, 3719
North Peachtree Road, Building 100
Chamblee, Georgia 30341, or emailed
(recommended) to acbcyw@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Jeremy McCallister, Designated Federal
Officer, National Center for Chronic
Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE, Mailstop F–76, Atlanta, Georgia
30341, Telephone: 404–639–7989;
Email: acbcyw@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of breast
health, breast cancer, disease prevention
and risk reduction, survivorship
(including metastatic breast cancer),
hereditary breast and ovarian cancer
(HBOC), or in related disciplines with a
specific focus on young women. Persons
with personal experience with early
onset breast cancer are also eligible to
apply. This includes but may not be
limited to breast cancer survivors <45
years of age and caregivers of said
persons. Federal employees will not be
considered for membership. Members
may be invited to serve up to four-year
terms. Election of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACBCYW
objectives (https://www.cdc.gov/faca/
committees/acbcyw.html).
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
PO 00000
Frm 00081
Fmt 4703
Sfmt 9990
83963
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACBCYW membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in November 2021,
or as soon as the HHS selection process
is completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. Government. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–28380 Filed 12–22–20; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 85, Number 247 (Wednesday, December 23, 2020)]
[Notices]
[Page 83963]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28380]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Breast Cancer in Young Women (ACBCYW)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the ACBCYW. The ACBCYW consists
of 15 experts in fields associated with breast cancer, disease
prevention, early detection, diagnosis, public health, social
marketing, genetic screening and counseling, treatment, rehabilitation,
palliative care, and survivorship in young women, or in related
disciplines with a specific focus on young women.
DATES: Nominations for membership on the ACBCYW must be received no
later than March 12, 2021. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Jeremy McCallister, c/o
ACBCYW Secretariat, Centers for Disease Control and Prevention, 3719
North Peachtree Road, Building 100 Chamblee, Georgia 30341, or emailed
(recommended) to [email protected].
FOR FURTHER INFORMATION CONTACT: Jeremy McCallister, Designated Federal
Officer, National Center for Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway NE, Mailstop F-76, Atlanta, Georgia
30341, Telephone: 404-639-7989; Email: [email protected].
SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals
who have expertise and qualifications necessary to contribute to the
accomplishments of the committee's objectives. Nominees will be
selected based on expertise in the fields of breast health, breast
cancer, disease prevention and risk reduction, survivorship (including
metastatic breast cancer), hereditary breast and ovarian cancer (HBOC),
or in related disciplines with a specific focus on young women. Persons
with personal experience with early onset breast cancer are also
eligible to apply. This includes but may not be limited to breast
cancer survivors <45 years of age and caregivers of said persons.
Federal employees will not be considered for membership. Members may be
invited to serve up to four-year terms. Election of members is based on
candidates' qualifications to contribute to the accomplishment of
ACBCYW objectives (https://www.cdc.gov/faca/committees/acbcyw.html).
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning and annually during their
terms. CDC reviews potential candidates for ACBCYW membership each year
and provides a slate of nominees for consideration to the Secretary of
HHS for final selection. HHS notifies selected candidates of their
appointment near the start of the term in November 2021, or as soon as
the HHS selection process is completed. Note that the need for
different expertise varies from year to year and a candidate who is not
selected in one year may be reconsidered in a subsequent year.
Nominees must be U.S. citizens, and cannot be full-time employees
of the U.S. Government. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-28380 Filed 12-22-20; 8:45 am]
BILLING CODE 4163-18-P
